142 related articles for article (PubMed ID: 38187248)
1. In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized.
Liang Y; He S; Tan Y; Liu Q; Zhao F; Liu T; Huang C; Lu X; Zheng S
Heliyon; 2024 Jan; 10(1):e23582. PubMed ID: 38187248
[TBL] [Abstract][Full Text] [Related]
2. SLC1A5, unrelated to prognosis, was associated with CD8
Zheng S; Liu T; Li L; Liu Q; Huang C; Liang Y; Tan Y; Zhang L; Lu X
Heliyon; 2023 Mar; 9(3):e14571. PubMed ID: 36950604
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma.
Zhong X; He Z; Fan Y; Yin L; Hong Z; Tong Y; Bi Q; Zhu S
Aging (Albany NY); 2023 Oct; 15(19):10640-10680. PubMed ID: 37827692
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocyte signature in epithelial and stromal compartments of an esophageal squamous cell carcinoma acidic microenvironment mediated by MCT4.
Zheng S; Liu T; Li L; Liu Q; Yang L; Zhang Q; Lu X
Pathol Res Pract; 2022 Aug; 236():153954. PubMed ID: 35667197
[TBL] [Abstract][Full Text] [Related]
5. MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.
Tao Z; Suo H; Zhang L; Jin Z; Wang Z; Wang D; Wu M; Peng N; Zhao Y; Chen B
Onco Targets Ther; 2020; 13():12255-12268. PubMed ID: 33273831
[TBL] [Abstract][Full Text] [Related]
6. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
8. Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer.
Ye H; Zhang N
Comput Math Methods Med; 2021; 2021():1498924. PubMed ID: 34868337
[TBL] [Abstract][Full Text] [Related]
9. PES1 reduces CD8
Ma N; Hua R; Yang Y; Liu ZC; Pan J; Yu BY; Sun YF; Xie D; Wang Y; Li ZG
J Biomed Sci; 2023 Mar; 30(1):20. PubMed ID: 36959575
[TBL] [Abstract][Full Text] [Related]
10. Tumor marker index based on preoperative SCC and CYFRA 21-1 is a significant prognostic factor for patients with resectable esophageal squamous cell carcinoma.
Qiao Y; Chen C; Yue J; Yu Z
Cancer Biomark; 2019; 25(3):243-250. PubMed ID: 31282406
[TBL] [Abstract][Full Text] [Related]
11. MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.
Cai M; Li H; Chen R; Zhou X
Cancer Manag Res; 2021; 13():2009-2024. PubMed ID: 33658859
[TBL] [Abstract][Full Text] [Related]
12. MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma.
Du F; Dong D; Zhang X; Jia J
Technol Cancer Res Treat; 2021; 20():15330338211052142. PubMed ID: 34761715
[No Abstract] [Full Text] [Related]
13. Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.
Wang Y; Song T; Li K; Liu H; Han Y; Xu T; Cao F; Li Y; Yu Y
World J Surg Oncol; 2022 Jul; 20(1):236. PubMed ID: 35840985
[TBL] [Abstract][Full Text] [Related]
14. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
[TBL] [Abstract][Full Text] [Related]
15. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
17. [High expression of MRPL13 promotes cell cycle progression and proliferation of gastric cancer cells by inhibiting p53 signaling to affect long-term prognosis].
Wang L; Xia Y; Zhang Z; Liu X; Shi J; Wang Y; Li J; Zhnag X; Geng Z; Song X; Zuo L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1558-1566. PubMed ID: 37814870
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma.
Wang Q; Feng F; Wang F; Liu Z; Liu S; Xu G; Zheng G; Guo M; Lian X; Zhang H
J Cancer; 2018; 9(12):2224-2231. PubMed ID: 29937943
[No Abstract] [Full Text] [Related]
19. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
